相关实验视频

Updated: Jan 18, 2026

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Published on: November 22, 2021

基于BEVS的H5N1流感病毒样颗粒诱导强大的功能抗体和免疫反应

Yongbo Qiao¹, Mengru Tang², Mo Du³

¹Changchun Institute of Biological Products Co.,Ltd, Changchun, China; State Key Laboratory of Novel Vaccines for Emerging Infectious Diseases, China National Biotec Group Company Limited, Beijing, China.

|September 8, 2025

概括

一种新的血凝素 (HA) 病毒样颗粒 (VLP) 候选疫苗已开发用于禽流感. 与传统流感疫苗相比,这种新型VLP疫苗显示出优越的免疫性和增强的免疫反应.

科学领域:

病毒学病毒学
疫苗学疫苗学疫苗学
生物技术是生物技术.

背景情况:

禽流感病毒构成重大流行病风险.
目前的流感疫苗有局限性,需要开发新的疫苗.

研究的目的:

开发和表征一种新的血凝素 (HA) 病毒样颗粒 (VLP) 候选禽流感疫苗.
在小鼠模型中评估开发的HA VLP疫苗的免疫性和有效性.

主要方法:

一个baculovirus表达载体系统 (BEVS) 被用来产生HA VLP.
工程VLP结合了来自H5N1的HA和来自H1N1的矩阵1 (M1) 蛋白.
在小鼠模型中进行的免疫研究使用了主要增强方案.

主要成果:

纯化HA VLP与原生流感病毒具有形态相似性,并保留了关键的生物特性.
与对照组相比,用VLP免疫的小鼠表现出显著增强的幽默和细胞免疫反应.
这种HA VLP候选疫苗在HA单体和三元化HA配方中表现出优越的免疫性.

结论:

开发的HA VLP候选疫苗是传统流感疫苗的有希望的替代品.
基于VLP的疫苗为开发下一代流感疫苗提供了一个潜在的优越平台.
需要进一步的研究和开发,以推进基于VLP的疫苗,以预防流感大流行.

关键词:

细菌病毒病毒的病毒.流感是一次流感.血凝素,类似病毒的颗粒.

更多相关视频

Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System

Expression of Functional Recombinant Hemagglutinin and Neuraminidase Proteins from the Novel H7N9 Influenza Virus Using the Baculovirus Expression System

Published on: November 6, 2013

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

相关概念视频

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Humoral Immune Responses

Humoral Immune Responses

Vaccinations

Vaccinations